Karam Al-Issa, M.D.
Hematology & Oncology Physician · Indianapolis, IN
Karam Al-Issa, M.D. is a hematology & oncology physician with a practice address in Indianapolis, Indiana, and NPI 1720468259, issued on May 29, 2015. Check the license (Indiana 01080058A, as entered in NPPES) on the Medical Licensing Board of Indiana; the Medicare figures below come from public CMS files.
- Name
- Karam Al-Issa
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 01080058A IN
Self-reported in NPPES; status is on the state search - Practice location
- 535 Barnhill Dr, Indianapolis, IN 46202
- Phone
- (317) 948-6942
- Enumerated
- May 29, 2015
- Record last updated
- Sep 27, 2021 (not updated in 5 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20201006003202); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 535 Barnhill Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Huisi AiStudent in an Organized Health Care Education/Training Program1841676582
- Fatemeh Ardeshir Larijani, MDHematology (Internal Medicine) Physician1861923500
- Peter Arnold, MDStudent in an Organized Health Care Education/Training Program1346945102
- Francis Asamoah, MDRadiation Oncology Physician1619455987
- Maya Ataya, MDStudent in an Organized Health Care Education/Training Program1639965346
- Linda BattiatoRegistered Nurse1043635410
Verify Karam Al-Issa in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Licensing Board of Indiana
Search for license 01080058ACheck the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
About as many Medicare Part D claims as the average hematology & oncology physician in 2024
873 Medicare Part D claims for 181 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 36% of claims. 56 claims were for opioids.
Most prescribed
- Eliquis150 claims
- Prochlorperazine Maleate70 claims
- Anastrozole40 claims
- Allopurinol38 claims
- Acyclovir32 claims
- Letrozole31 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 28.7 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $17,748.89
101 payments; by number, the most common kind was food and beverage; the largest payer was Pfizer Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Indiana University Health IncIndianapolis, IN
- IU Health Medical Group LLCIndianapolis, IN
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Hematology & Oncology Physician providers in Indiana
There are 245 hematology & oncology physician records in Indiana.
Other hematology & oncology physician records in Indiana
- Paolo Abada, MDIndianapolis, IN1780844506
- Mohammad Abu Zaid, M.D.Kokomo, IN1720392798
- Nabil Adra, MDIndianapolis, IN1811285893
- Lakshmi Aggarwal, MDFort Wayne, IN1528060431
- Maqbool Ahmed, M.D.Evansville, IN1023022118
- Sameer Ahmed, MD, MBBSIndianapolis, IN1982723227
- Maxwell Akanbi, MDFort Wayne, IN1457977613
- Haitham Al-Okk, MDVincennes, IN1891891180
- Mohammed Ali, M.D.Munster, IN1386612448
- Abeer Alqaisi, MDKokomo, IN1356514608
Common questions
What is Karam Al-Issa, M.D.'s NPI number?
Karam Al-Issa, M.D.'s National Provider Identifier (NPI) is 1720468259, issued on May 29, 2015. An NPI identifies a provider in billing; it is not a license.
Where is Karam Al-Issa, M.D. located?
The NPPES record lists a practice address at 535 Barnhill Dr, Indianapolis, IN, 46202. Phone: (317) 948-6942. Providers update this record themselves, so call before visiting.
How can I verify Karam Al-Issa, M.D.'s license?
NPPES lists Indiana license number 01080058A, as entered by the provider. Search the Medical Licensing Board of Indiana at https://www.in.gov/pla/professions/physicians-home/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Karam Al-Issa, M.D. prescribe under Medicare Part D?
In 2024, Karam Al-Issa, M.D. had 873 Medicare Part D claims for 181 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
What is Karam Al-Issa, M.D.'s MIPS final score?
The 2023 MIPS final score is 28.7 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.